Epidemiologic Studies of Workplace Exposure to Environmental Tobacco Smoke and Cardiovascular Disease
This article reviews the methods and findings of published studies addressing the relationship between workplace exposure to environmental tobacco smoke (ETS) and the risk of cardiovascular disease. Using the MEDLINE database (National Library of Medicine, Bethesda, MD), we conducted a search of the published peer-reviewed literature linking ETS to cardiovascular disease. All studies located in this database were reviewed to determine if the investigators specifically examined workplace exposure to ETS. We identified six published epidemiologic studies-three case-control studies (1) (2) (3) and three cohort studies (4-6)-that examined the relationship between ETS exposure in the workplace and risk of cardiovascular disease.
Considering current exposure to ETS in the workplace, the point estimates of the odds ratios/relative risks for cardiovascular disease exceeded 1.0 (range, 1.2-1.9) in five of the six studies, although none of the estimates was statistically significant (Table 1, Figure 1 ). The imprecision of the risk estimates (with the exception of the large American Cancer Society CPS-II cohort) (5) reflects the relatively small number of cardiovascular events occurring in the individual studies.
Recently, Wells (7) reported a metaanalysis of the published and unpublished studies on the relationship of passive smoking in the workplace and risk of cardiovascular disease. In addition to the six published studies included in this survey (1) (2) (3) (4) (5) (6) , the meta-analysis by Wells included data from two unpublished doctoral dissertations (8, 9) . These eight studies yielded a pooled relative risk estimate of 1.18 (95% confidence interval [CI], 1.04-1.34) (7) . Since the purpose of the present review was not to replicate Wells' meta-analysis, we will not further consider the unpublished dissertations. We will review the six published studies (1) (2) (3) (4) (5) (6) from the perspective of their adequacy in measuring ETS exposure at work, addressing issues of confounding, and assessing dose-response relations.
Assessment of ETS Exposure
Environmental tobacco smoke exposure was assessed in all studies by interview (case-control studies) or self-completed questionnaire (cohort studies). With the exception of the case-control study by Dobson et (12) . Although there are dietary and other noninhaled sources of nicotine, these are likely to make a negligible contribution to cotinine levels (13, 14) . * Inaccuracy of self-reported intensity of exposure to ETS. Self-reported current exposure to passive smoking correlates only modestly (Pearson coefficients ranging between 0.2 and 0.5) with biochemical markers such as salivary (12) and urinary (15) cotinine. This is likely to result in a bias toward the null in estimates of dose-response relations between intensity of ETS exposure and risk of disease. * Downward secular trends in ETS exposure. The prevalence of passive smoking has declined during the past decade in countries such as the United States since (Table 3) , would continue to count individuals as exposed even though exposure ceased during the course of the study and these individuals presumably benefited from reduced risks of cardiovascular disease. In other words, these studies probably have underestimated the risk ofdisease.
Confounding
Individuals exposed to passive smoking at home are less healthy with respect to other lifestyle habits compared to unexposed individuals (10, 16, 17) . However, little has been documented about differences in health habits comparing those individuals exposed to ETS in the workplace to those not exposed. It is likely, however, that voluntary restrictions on workplace smoking are less common in blue-collar occupations and that workers employed in these jobs tend to have fewer health-conscious health habits than white-collar workers.
Given the relatively modest associations between passive smoking and cardiovascular disease, it is important to exclude confounding as an explanation for the observed association. Of the studies that examined ETS exposure in the workplace and cardiovascular disease, only three (2, 5, 6) managed to adjust for a reasonably broad range of potential confounding factors (Table 1) . In all three studies, adjustment for confounding factors resulted in some reduction of the risk estimates. In the case-control study by He et (2), it was not possible to assess the extent of this problem. In two cohort studies (5, 6) , adjustment for confounding resulted in a very modest reduction (2-11%) in the relative risks (Table 1) . Overall, unadjusted confounding is believed to result in a small bias in overestimating the risk of passive smoking on cardiovascular disease (10, 18, 19) .
Ascertainment of Disease End Points
In total, the evidence on ETS exposure in the workplace and risk of cardiovascular disease is based upon 1,594 end points, to which the American Cancer Society CPS-II cohort (5) contributed 68% of cases (Table 3 ). The six studies used different definitions of ( (20) to confirm cardiovascular disease end points (1,2,6); two studies (3, 5) used the International Classification ofDiseases, 9th revision codes (21) ; in one case, the Multiple Risk Factor Intervention Factor study (4) intensity of exposure and/or the possibility that ETS increases cardiovascular disease risk via acute mechanisms so that increasing duration of exposure does not contribute to further increases in risk. In assessment of current ETS exposure compared to cumulative duration of exposure, Pron et al. (22) found that self-reported duration of exposure was less reliable than the assessment of recent passive smoking exposure. In that study, a correlation coefficient of 0.25 was found between the reported durations of exposure to spousal smoking at the initial and repeat interviews. When misclassification of exposure duration is minimized, it may be possible to observe a dose-response relation to cardiovascular disease risk. For example, Steenland et al. (5) found evidence for a dose-response relation between duration of home exposure to ETS and risk of cardiovascular disease risk when their analysis was restricted to the subgroup of the American Cancer Society CPS-II cohort in whom reports of exposure to ETS were concordant for both self-reports and spousal reports.
Alternatively, some authors have suggested that the mechanisms by which ETS increases the risk of cardiovascular disease are short-term (in which case, increasing duration of ETS exposure may not produce increasing risk of disease). On the basis of data from published experimental studies, Law et al. (23) calculated effects of tobacco smoke exposure on platelet aggregation. In experiments, exposure to secondhand smoke for 20 min resulted in a 1.03-standard deviation increase in platelet aggregation, whereas actually smoking one to two cigarettes was associated with about a 1.25-standard deviation increase (24) . The effect of tobacco smoke exposure on platelet aggregation is believed to be acute; 1 hr after a single exposure, the effect on platelet aggregation is nearly halved. Working from this experimental evidence, Law et al. (23) calculated that repeated exposure to tobacco smoke throughout the day (such as experienced by a regular passive smoker) could be consistent with a 20-30% elevation in risk of cardiovascular disease.
For both men and women, the prevalence of exposure to ETS in the workplace was substantially higher than in the home in these six studies ( Table 2 ). The sole exception was the study from China by He et al. (2) in which women reported a higher prevalence of exposure to ETS at home than at work. None of the studies assessed the intensity of ETS exposure at home and in the workplace, so that it is possible that home exposure may be more intense than workplace exposure (25, 26) . Conversely, environmental monitoring studies suggest that for many groups of workers occupational exposure may involve a higher density of smokers in the immediate environment (27, 28) . Additionally, many individuals spend more time at work than in the company of their spouses at home.
Despite the higher prevalence of ETS exposure in the workplace than in the home, the evidence linking ETS to cardiovascular disease is more consistent and abundant for home exposure. The reason for the wealth of evidence for home exposure is because many epidemiologic studies have been able to use proxy measures of exposure to spousal tobacco smoke (i.e., using "married to a smoker" as an indicator of ETS exposure at home). The point estimates for home and workplace exposure are similar, however, and the 95% CI values overlap in most cases. For example, in the study by Kawachi et al. (6) , among women exposed only at work and not at home, the adjusted relative risks of total coronary heart disease (CHD) were 1.49 (95% CI, 0.71-3.14) among those occasionally exposed and 1.92 (95% CI, 0.88-4.18) among those regularly exposed to ETS. Among women exposed only at home and not at work, the corresponding adjusted relative risks were 1.19 
Conclusions
In contrast to the evidence on spousal exposure to ETS and cardiovascular disease, studies of ETS exposure in the workplace are still sparse and inconclusive. Although the point estimates of risk for cardiovascular disease exceeded 1 .0 in five of six studies, none of the relative risks was statistically significant because of the small number of cardiovascular end points occurring in individual studies (except for the American Cancer Society CPS-II study). All the published studies assessed ETS exposure in the workplace by self-report (interviews or questionnaires). In common with most epidemiologic studies of ETS, none of the workplace studies provided independent biochemical validation of ETS exposure. However, most exposure misclassifications in these studies are likely to be minor and may have introduced a conservative bias in the estimation of risk. Potential confounding is possibly a more important issue in studies of cardiovascular disease than in studies of lung cancer, but three of the six published studies adjusted for a broad range of potential confounding factors, and two of these found evidence of increased risk of cardiovascular disease with ETS exposure in the workplace. Further studies are needed to conclusively demonstrate an effect of ETS exposure in the workplace on cardiovascular disease risk. In particular, studies are needed to relate the intensity and duration of ETS exposure at work to cardiovascular disease risk. Despite the sparsity of evidence on workplace exposure, however, there is little biologically plausible reason to believe that the hazards of ETS exposure that have been demonstrated in the home setting should not also apply to the work setting.
